12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·10/03/2024 12:06:20

Listen to the news

Gainers

Theriva Biologics (AMEX:TOVX) shares moved upwards by 53.2% to $1.9 during Thursday's pre-market session. The company's market cap stands at $2.5 million.
Conduit Pharmaceuticals (NASDAQ:CDT) shares moved upwards by 22.1% to $0.12. The company's market cap stands at $11.1 million.
ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 14.0% to $0.23. The market value of their outstanding shares is at $4.1 million.
Syra Health (NASDAQ:SYRA) shares increased by 13.45% to $0.42. The company's market cap stands at $4.1 million.
Bio-Path Hldgs (NASDAQ:BPTH) shares rose 12.01% to $0.99. The company's market cap stands at $2.5 million.
Redhill Biopharma (NASDAQ:RDHL) shares rose 10.69% to $8.9. The market value of their outstanding shares is at $11.3 million.

Losers

Windtree Therapeutics (NASDAQ:WINT) stock decreased by 16.0% to $1.21 during Thursday's pre-market session. The company's market cap stands at $1.9 million.
Soligenix (NASDAQ:SNGX) stock fell 14.79% to $4.15. The market value of their outstanding shares is at $9.4 million.
Kazia Therapeutics (NASDAQ:KZIA) shares decreased by 11.59% to $0.39. The market value of their outstanding shares is at $11.4 million.
ALT5 Sigma (NASDAQ:ALTS) stock declined by 11.3% to $1.58. The market value of their outstanding shares is at $21.3 million.
Pasithea Therapeutics (NASDAQ:KTTA) stock decreased by 9.63% to $4.44. The company's market cap stands at $4.6 million.
Hims & Hers Health (NYSE:HIMS) stock decreased by 9.08% to $17.23. The company's market cap stands at $3.7 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English